Nishikawa, J.; Iizasa, H.; Yoshiyama, H.; Shimokuri, K.; Kobayashi, Y.; Sasaki, S.; Nakamura, M.; Yanai, H.; Sakai, K.; Suehiro, Y.;
et al. Clinical Importance of Epstein–Barr Virus-Associated Gastric Cancer. Cancers 2018, 10, 167.
https://doi.org/10.3390/cancers10060167
AMA Style
Nishikawa J, Iizasa H, Yoshiyama H, Shimokuri K, Kobayashi Y, Sasaki S, Nakamura M, Yanai H, Sakai K, Suehiro Y,
et al. Clinical Importance of Epstein–Barr Virus-Associated Gastric Cancer. Cancers. 2018; 10(6):167.
https://doi.org/10.3390/cancers10060167
Chicago/Turabian Style
Nishikawa, Jun, Hisashi Iizasa, Hironori Yoshiyama, Kanami Shimokuri, Yuki Kobayashi, Sho Sasaki, Munetaka Nakamura, Hideo Yanai, Kohei Sakai, Yutaka Suehiro,
and et al. 2018. "Clinical Importance of Epstein–Barr Virus-Associated Gastric Cancer" Cancers 10, no. 6: 167.
https://doi.org/10.3390/cancers10060167
APA Style
Nishikawa, J., Iizasa, H., Yoshiyama, H., Shimokuri, K., Kobayashi, Y., Sasaki, S., Nakamura, M., Yanai, H., Sakai, K., Suehiro, Y., Yamasaki, T., & Sakaida, I.
(2018). Clinical Importance of Epstein–Barr Virus-Associated Gastric Cancer. Cancers, 10(6), 167.
https://doi.org/10.3390/cancers10060167